spacer
home > pmps > winter 2017 > breathing space
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Breathing Space

Inhalation technology is considered to be one of the most feasible administration options for patients as, unlike other methods of application, it is painless and flexible. This drug delivery technology is gaining increasing importance for the treatment of asthma, chronic obstructive pulmonary disease (COPD), respiratory allergies and cystic fibrosis, among others. Due to the large surface area presented by the respiratory tract, this route expedites drug absorption and onset action, while allowing for smaller doses to be administered. It has also been found to increase patient compliance.

However, there are various disadvantages associated with inhalation technology such as:
  • Persistent drug irritation
  • The risk of toxic particles affecting the lungs
  • Drug stability issues
  • Deposition of aerosolised particles in the oropharyngeal area and within the upper airway


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
With over 10 years of experience in market research and consulting, Rajiv Kalia is Associate Director of Healthcare at MarketsandMarkets. He endeavours to constantly track and analyse healthcare market developments and research areas for the team. Prior to joining MarketsandMarkets, he has worked with WNS Global Services and Smartanalyst India Private Limited in similar areas.

With over five years of experience in healthcare market research and consulting, Ruchika Kakarya is a Senior Research Analyst of Healthcare at MarketsandMarkets. She specialises in market size estimations and building forecast models. Prior to joining MarketsandMarkets, Ruchika worked with WNS Global Services and Global Data Research Center in similar areas.

Experienced in market research and report writing, Pooja Ganguly is a Research Associate of Healthcare at MarketsandMarkets. With her strong technical, analytical knowledge, she provides business and market analysis solutions with detailed attention on forecasting, competitive intelligence, pricing analysis, identifying revenue pockets, understanding usage patterns and trends and supplyand demand-side analysis.
spacer
Rajiv Kalia
spacer
spacer
spacer
Ruchika Kakarya
spacer
spacer
spacer
Pooja Ganguly
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Destiny Pharma appoints MedPharm to develop new XF-platform drug formulations

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs, is pleased to announce that it has appointed MedPharm as its expert partner to develop new topical formulations of the Company’s novel XF-platform compounds. These new treatments for dermal and ocular infections are part of its second clinical programme to address the global problem of anti-microbial resistance (AMR). MedPharm is a world leading contract provider of topical and transdermal product design and formulation development services using sophisticated in vitro models to de-risk development programmes.
More info >>

White Papers

The Flexible Factory Concept: A flexible bioprocessing platform to meet the changing needs of biomanufacturing

GE Healthcare Life Sciences

For the past several years, the biopharma industry has been buffeted by dynamic market conditions that are rapidly reshaping manufacturing requirements. These factors include: • The rise of small-market pharmaceuticals that do not require the production scale of the previous “blockbuster” drug model • Increased titers and process productivity that generate more bulk-product within a much smaller manufacturing footprint • The emergence of biosimilars and continued evolution of healthcare reform, which will increasingly pressure drug pricing and require greater cost discipline • Greater competition and shorter patent protection timelines, which will further ratchet up time-to-market pressures • Tighter capital markets that will create heightened scrutiny for all new investment projects
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement